↓ Skip to main content

Cannabinoid treatment for autism: a proof-of-concept randomized trial

Overview of attention for article published in Molecular Autism, February 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#38 of 720)
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
6 news outlets
twitter
87 X users
facebook
2 Facebook pages

Citations

dimensions_citation
73 Dimensions

Readers on

mendeley
262 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cannabinoid treatment for autism: a proof-of-concept randomized trial
Published in
Molecular Autism, February 2021
DOI 10.1186/s13229-021-00420-2
Pubmed ID
Authors

Adi Aran, Moria Harel, Hanoch Cassuto, Lola Polyansky, Aviad Schnapp, Nadia Wattad, Dorit Shmueli, Daphna Golan, F. Xavier Castellanos

X Demographics

X Demographics

The data shown below were collected from the profiles of 87 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 262 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 262 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 26 10%
Researcher 21 8%
Student > Master 18 7%
Student > Ph. D. Student 14 5%
Student > Postgraduate 11 4%
Other 44 17%
Unknown 128 49%
Readers by discipline Count As %
Medicine and Dentistry 41 16%
Pharmacology, Toxicology and Pharmaceutical Science 18 7%
Psychology 13 5%
Neuroscience 9 3%
Biochemistry, Genetics and Molecular Biology 9 3%
Other 41 16%
Unknown 131 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 102. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 May 2023.
All research outputs
#416,592
of 25,563,770 outputs
Outputs from Molecular Autism
#38
of 720 outputs
Outputs of similar age
#12,416
of 531,828 outputs
Outputs of similar age from Molecular Autism
#3
of 25 outputs
Altmetric has tracked 25,563,770 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 720 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.2. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 531,828 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.